Skip to main content
. 2023 Jul 18;27(5):583–592. doi: 10.1007/s40291-023-00655-0
A highly specific, sensitive and cost-effective (£0.96/test) immunoassay for the detection of exposure to SARS-CoV-2 was developed.
This assay identifies individuals who have been infected with SARS-CoV-2 from those with no previous exposure.
The protocol is easy to run and can be easily applied in other developing countries to detect previous exposure to SARS-CoV-2 patients from Ghana.